Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts

被引:2
|
作者
Zhao, Chongyu [1 ]
He, Chaobin [1 ]
Lu, Jiawei [2 ]
Huang, Xin [1 ]
Chen, Cheng [3 ]
Lin, Xiaojun [1 ]
机构
[1] Sun Yat sen Univ, Dept Pancreatobiliary Surg, State Key Lab Oncol South China, Collaborat Innovat Centerfor Canc Med Canc Ctr, Guangzhou, Peoples R China
[2] Dalian Med Univ, Dept Oncol, Hosp 2, Dalian, Peoples R China
[3] Dalian MedicalUnivers, Dept Cardiol, Affiliated Hosp 1, Dalian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
intrahepatic cholangiocarcinoma; post-progression survival; recurrence; prognosis; nomogram; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; RESECTION; DIAGNOSIS; PREDICT;
D O I
10.3389/fonc.2022.832038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This study aimed at developing a novel nomogram for predicting PPS in recurred iCCA patients. MethodClinical characteristics were retrospectively collected in 396 patients diagnosed with iCCA from cohorts of Sun Yat-sen University Cancer Center (SYSUCC) and the First Hospital of Dalian Medical University (FHDMU). The PPS in patients with different progression patterns was investigated. The nomogram of PPS was established with the Cox regression model in the primary cohort. Then the nomogram was verified in the external validation cohort. ResultsLiver progression was the commonest pattern (42.08%) in recurred iCCA patients, while patients with local LN progression had significantly better PPS than those with other patterns. The independent prognostic factors comprised elevated CEA levels, tumor differentiation, N stage 8th, adjuvant therapy, Local LN metastasis, Liver Metastasis only, and Multiple Metastasis. The nomogram constructed on these factors achieved satisfied C-indexes of 0.794 (95% CI 0.769-0.828) and 0.827 (0.779-0.876) for the training and validation cohorts, respectively. These values were significantly higher than those of the 8th TNM stage system (all p < 0.001). The recurred iCCA patients could be precisely classified into high- and low-risk groups according to the cutoff point of this nomogram (p < 0.01). ConclusionThe investigation of progression patterns and the development of this nomogram can offer new evidence to precisely postoperative and post-progression management of iCCA patients.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitors Affect Post-Progression Survival of Specific Patient Subgroups With Advanced Hepatocellular Carcinoma: A Study Cohorts' Analysis
    Colloca, Giuseppe A.
    Venturino, Antonella
    JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (11-12) : 655 - 663
  • [32] A novel prognostic nomogram for patients with surgically resected perihilar cholangiocarcinoma: a SEER-based study
    Li, Pengfei
    Song, Lujun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (01)
  • [33] Survival Analysis and a Novel Nomogram Model for Progression-Free Survival in Patients with Prostate Cancer
    Han, Yuefu
    Wen, Xingqiao
    Chen, Dong
    Li, Xiaojuan
    Leng, Qu
    Wen, Yuehui
    Li, Jun
    Zhu, Weian
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [34] Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
    Lee, C. K.
    Simes, R. J.
    Brown, C.
    Lord, S.
    Wagner, U.
    Plante, M.
    Vergote, I.
    Pisano, C.
    Parma, G.
    Burges, A.
    Bourgeois, H.
    Hogberg, T.
    Bentley, J.
    Angleitner-Boubenizek, L.
    Ferrero, A.
    Richter, B.
    Hirte, H.
    Gebski, V.
    Pfisterer, J.
    Pujade-Lauraine, E.
    Friedlander, M.
    BRITISH JOURNAL OF CANCER, 2011, 105 (08) : 1144 - 1150
  • [35] Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
    C K Lee
    R J Simes
    C Brown
    S Lord
    U Wagner
    M Plante
    I Vergote
    C Pisano
    G Parma
    A Burges
    H Bourgeois
    T Högberg
    J Bentley
    L Angleitner-Boubenizek
    A Ferrero
    B Richter
    H Hirte
    V Gebski
    J Pfisterer
    E Pujade-Lauraine
    M Friedlander
    British Journal of Cancer, 2011, 105 : 1144 - 1150
  • [36] Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation
    Wu, Hao
    Liu, Gui-ju
    Zhang, Zhong-yi
    Wu, Wei
    Meng, Yuan-feng
    Wang, Song
    Yang, Wei
    Yan, Kun
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2021, 38 (01) : 633 - 639
  • [37] A Novel Biomarker-Based Preoperative Prognostic Grading System for Predicting Survival After Surgery for Intrahepatic Cholangiocarcinoma
    Yoh, Tomoaki
    Seo, Satoru
    Hatano, Etsuro
    Taura, Kojiro
    Fuji, Hiroaki
    Ikeno, Yoshinobu
    Okuda, Yukihiro
    Yasuchika, Kentaro
    Kaido, Toshimi
    Okajima, Hideaki
    Uemoto, Shinji
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (05) : 1351 - 1357
  • [38] Changes in the Mean Intrahepatic Target Computed Tomography Attenuation Value During Treatment May Be a Useful New Predictor of the Post-progression Survival Associated with Lenvatinib Treatment
    Muraishi, Nozomu
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Shindoh, Junichi
    Kobayashi, Yuta
    Okubo, Satoshi
    Iritani, Soichi
    Fujiyama, Shunichiro
    Hosaka, Tetsuya
    Saitoh, Satoshi
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Ikeda, Kenji
    Arase, Yasuji
    Hashimoto, Masaji
    Yasuda, Ichiro
    Kumada, Hiromitsu
    INTERNAL MEDICINE, 2022, 61 (07) : 951 - 958
  • [39] Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with Pazopanib
    Kattan, Michael W.
    Sternberg, Cora N.
    Mehmud, Faisal
    Bhatt, Kamal
    McCann, Lauren
    Motzer, Robert J.
    ONCOLOGY, 2015, 89 (04) : 235 - 241
  • [40] Clinical Impact of the Relationship between Post-Progression Survival and Overall Survival in Extensive Disease Small Cell Lung Cancer Patients
    Imai, Hisao
    Mori, Keita
    Watase, Nodoka
    Fujimoto, Sakae
    Kaira, Kyoichi
    Yamada, Masanobu
    Minato, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S726 - S727